August 6th 2025
Discover how Rolf-Markus Szeimies, MD, is revolutionizing at-home skin care with 5-ALA, enhancing cellular health and hydration in daily routines.
Low-dose STS minimizes risks while eradicating small veins
November 1st 2001Dallas - Low-dose sodium tetradecyl sulfate (STS, Sotradecol) is highly effective for sclerotherapy of small veins on the lower extremities but has the benefit of an enhanced safety profile relative to higher concentrations, Robert A. Weiss, M.D., said at the annual meeting of the American Society for Dermatologic Surgery.
Nonablative Nd:YAG useful tool for neck, lip rhytides
November 1st 2001Dallas - The 1320-nm Nd:YAG nonablative laser (CoolTouch II) can broaden opportunities for safe and effective photorejuvenation of aging skin, Elizabeth F. Rostan, M.D., said at the annual meeting of the American Society for Dermatologic Surgery.
Little things mean a lot to facial cosmetic surgery
November 1st 2001Dallas - A number of small things can make a big difference whenit comes to facial rejuvenation surgery, Frederick J. Menick, M.D., saidat the annual joint meeting of the American Society for Dermatologic Surgeryand the American College of Mohs Micrographic Surgery and Cutaneous Oncology.
Redistribute facial fat for rejuvenation
October 1st 2001New Haven, Conn. - Fat redistribution is the primary reason formorphologic alterations in the aging face, said Lisa M. Donofrio, M.D. Torestore the youthful appearance of most patients, fat augmentation thatrebuilds the facial planes of youth must be the main objective of any rejuvenationprocedure.
Composite nail grafts used for reconstruction
October 1st 2001Springfield, Ill. - A pivotal study undertaken at the Institutefor Plastic and Reconstructive Surgery at Southern Illinois University isthe first to evaluate a large series of patients receiving free compositematrix grafts in various conditions.
Combination therapy may be answer for CTCL
October 1st 2001Anaheim, Calif. - Combination therapy with biological responsemodifiers and careful and regular reassessment of refractory patients areof paramount importance in the effective treatment of cutaneous T-cell lymphoma,according to Carmela C. Vittorio, M.D.